Arcturus Therapeutics Holdings, Inc. (ARCT)
7.68
+0.47
(+6.52%)
USD |
NASDAQ |
May 27, 16:00
7.68
0.00 (0.00%)
After-Hours: 19:44
Arcturus Therapeutics Holdings Free Cash Flow : -63.18M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Twist Bioscience Corp. | -95.14M |
| Denali Therapeutics, Inc. | -419.23M |
| Agenus, Inc. | -87.53M |
| Curis, Inc. | -28.95M |
| Plus Therapeutics, Inc. | -21.72M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.44M |
| Cash from Investing (Quarterly) | 0.034M |
| Cash from Financing (Quarterly) | 0.016M |
| Free Cash Flow Per Share (Quarterly) | -0.684 |
| Free Cash Flow to Equity (Quarterly) | -18.43M |
| Free Cash Flow to Firm (Quarterly) | -19.44M |
| Free Cash Flow Yield | -29.69% |